|
|
Volumn 146, Issue 9, 2010, Pages 1044-1045
|
|
An evaluation of long-term outcomes in adults with pediatric-onset morphea
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINUCLEAR ANTIBODY;
CORTICOSTEROID;
METHOTREXATE;
ADULT;
AGED;
ARTICLE;
CHILD CARE;
CLINICAL ARTICLE;
HUMAN;
IMMUNOFLUORESCENCE;
MORPHEA;
PHYSICAL EXAMINATION;
PRIORITY JOURNAL;
QUALITY OF LIFE;
ADOLESCENT;
AGE DISTRIBUTION;
CHILD;
COHORT ANALYSIS;
EVALUATION STUDY;
FEMALE;
FOLLOW UP;
INCIDENCE;
MALE;
MIDDLE AGED;
ONSET AGE;
PRESCHOOL CHILD;
RECURRENT DISEASE;
RISK ASSESSMENT;
SCLERODERMA, LOCALIZED;
SEVERITY OF ILLNESS INDEX;
SEX RATIO;
TIME;
TREATMENT OUTCOME;
YOUNG ADULT;
ADOLESCENT;
ADRENAL CORTEX HORMONES;
ADULT;
AGE DISTRIBUTION;
AGE OF ONSET;
AGED;
CHILD;
CHILD, PRESCHOOL;
COHORT STUDIES;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INCIDENCE;
MALE;
METHOTREXATE;
MIDDLE AGED;
RECURRENCE;
RISK ASSESSMENT;
SCLERODERMA, LOCALIZED;
SEVERITY OF ILLNESS INDEX;
SEX DISTRIBUTION;
TIME FACTORS;
TREATMENT OUTCOME;
YOUNG ADULT;
|
|
EID: 77957141706
PISSN: 0003987X
EISSN: 15383652
Source Type: Journal
DOI: 10.1001/archdermatol.2010.239 Document Type: Article |
|
Times cited : (72)
|
|
References (6)
|
